RSLBX
Price
$71.50
Change
+$0.59 (+0.83%)
Updated
Jun 22 closing price
Net Assets
91.47B
TGSAX
Price
$10.57
Change
-$0.07 (-0.66%)
Updated
Jun 22 closing price
Net Assets
816.62M
Interact to see
Advertisement

RSLBX vs TGSAX

RSLBX vs TGSAX Comparison Chart in %
View a ticker or compare two or three
VS
RSLBX vs. TGSAX commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RSLBX is a Buy and TGSAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RSLBX has more cash in the bank: 91.5B vs. TGSAX (817M). TGSAX pays higher dividends than RSLBX: TGSAX (1.42) vs RSLBX (0.18). RSLBX was incepted earlier than TGSAX: RSLBX (24 years) vs TGSAX (29 years). RSLBX (1.74) is less costly to investors than TGSAX (1.09). RSLBX is a more actively managed with annual turnover of: 41.00 vs. TGSAX (15.75). RSLBX has a lower initial minimum investment than TGSAX: RSLBX (250) vs TGSAX (100000). RSLBX annual gain was more profitable for investors over the last year : 22.00 vs. TGSAX (16.30). RSLBX return over 5 years is better than : -6.61 vs. TGSAX (-8.98).
RSLBXTGSAXRSLBX / TGSAX
Total Expense Ratio1.741.09160%
Annual Report Gross Expense Ratio1.741.09160%
Fund Existence24 years29 years-
Gain YTD16.43111.181147%
Front LoadN/AN/A-
Min. Initial Investment2501000000%
Min. Initial Investment IRAN/AN/A-
Net Assets91.5B817M11,200%
Annual Yield % from dividends0.181.4212%
Returns for 1 year22.0016.30135%
Returns for 3 years38.6827.81139%
Returns for 5 years-6.61-8.9874%
Returns for 10 years83.5041.07203%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ACFOX82.27N/A
N/A
American Century Focused Dynamic Gr Inv
UMBHX28.65N/A
N/A
Carillon Chartwell Small Cap I
AMTAX11.54N/A
N/A
AB All Market Real Return A
MDOBX12.01N/A
N/A
Morgan Stanley Developing Opportunity C
JVACX39.17N/A
N/A
JPMorgan Value Advantage C